Neurogene (NGNE) Interest Expenses (2013 - 2026)

Neurogene's Interest Expenses history runs 14 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• Quarterly Interest Expenses rose 928.57% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 928.57% YoY) and the FY2025 annual result came in at $139.8 million, up 21.57% from the prior year.
• Interest Expenses was $7.2 million for Q1 2026 at Neurogene, up from $1000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $38.2 million in Q4 2022 and bottomed at $1000.0 in Q4 2025.
• A 5-year average of $7.1 million and a median of $700000.0 in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2023 — Interest Expenses slumped 99.99% — and 2024, when it soared 1073233.33%.
• Neurogene's Interest Expenses stood at $38.2 million in 2022, then slumped by 99.99% to $3000.0 in 2023, then jumped by 128933.33% to $3.9 million in 2024, then tumbled by 99.97% to $1000.0 in 2025, then soared by 719900.0% to $7.2 million in 2026.
• Business Quant data shows NGNE's Interest Expenses at $7.2 million in Q1 2026, $1000.0 in Q4 2025, and $2.9 million in Q3 2025.